Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues-Reference-Cited by-同舟云学术

Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues

Published:2018-11-20 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Robles Juan Pablo,Zamora Magdalena,Velasco-Bolom José Luis,Tovar Miriam,Garduño-Juárez Ramón^ORCID,Bertsch Thomas,Martínez de la Escalera Gonzalo,Triebel Jakob^ORCID,Clapp Carmen

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-35383-7.pdf

Reference77 articles.

1. Chung, A. S. & Ferrara, N. Developmental and pathological angiogenesis. Annual review of cell and developmental biology 27, 563–584, https://doi.org/10.1146/annurev-cellbio-092910-154002 (2011).

2. Folkman, J. Angiogenesis. Annual review of medicine 57, 1–18, https://doi.org/10.1146/annurev.med.57.121304.131306 (2006).

3. Ferrara, N. & Kerbel, R. S. Angiogenesis as a therapeutic target. Nature 438, 967–974, https://doi.org/10.1038/nature04483 (2005).

4. Nyberg, P., Xie, L. & Kalluri, R. Endogenous inhibitors of angiogenesis. Cancer Res 65, 3967–3979, https://doi.org/10.1158/0008-5472.CAN-04-2427 (2005).

5. Cao, Y. Endogenous angiogenesis inhibitors and their therapeutic implications. The international journal of biochemistry & cell biology 33, 357–369 (2001).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunometric and functional measurement of endogenous vasoinhibin in human sera;Frontiers in Endocrinology;2024-04-29

2. Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif;Endocrinology;2023-12-06

3. 14K Prolactin Derived 14-Mer Antiangiogenic Peptide Targets Bradykinin-/Nitric Oxide-cGMP-Dependent Angiogenesis;2023-08-21

4. The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif;2023-08-19

5. Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited;Frontiers in Endocrinology;2022-09-09